Rapid Diagnostic Test for Sepsis Validated for Emergency Department
Researchers presented data that validate a rapid diagnostic test for sepsis at the American Thoracic Society 2023 International Conference.
Category: Sepsis
Sepsis
Latest
Sepsis
Latest
Timely Diagnosis: Improving Outcomes in Sepsis and Antimicrobial Resistance
Improving outcomes with sepsis is dependent on timely diagnosis and treatment. Culture-independent testing is one way to save time.
Sepsis
Latest
NanoDx Collaborates with IBM Research on Sensors for Rapid Diagnostic Testing
NanoDx, Inc., has entered into a licensing agreement with IBM Research for use of its nanoscale sensors for accurate, rapid testing.
T2 Biosystems Receives Multiyear Innovative Technology Contract from Vizient
The contract covers the T2Dx instrument as well as the T2Bacteria and T2Candida panels, which detect sepsis-causing bacterial and fungal pathogens directly from whole blood.
Read MoreT2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer
Sperzel succeeds John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read More
Ontera and QuantuMDx Collaborate to Advance Sepsis Diagnosis
The technology will be based on QuantuMDx’s rapid cell/sample preparation technology, Capture-XT, and Ontera’s nanopore biosensor, currently utilized in its Sam and Duo Nano platforms.
Read MoreDiagnostics Startups Take On Growing Threat of Antibiotic-Resistant Bugs
A new breed of diagnostic companies is rolling out technologies to tackle a growing and deadly health-care problem: antibiotic-resistant bugs
Read MoreT2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer
T2 Biosystems has announced the appointment of diagnostics industry veteran John Sperzel as president and chief executive officer, succeeding John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read More
Speeding Diagnosis in Sepsis Care
Rapid molecular diagnostics contribute to improved patient outcomes.
Read MoreBeckman Coulter Receives BARDA Funding to Develop Early Sepsis Detection Algorithm
Beckman Coulter and Dascena will collaborate to develop and commercialize a novel machine-learning-based algorithm for the detection of sepsis.
Read More
Rapid IVD Aims to Alleviate Global Antimicrobial Resistance Crisis
Gradientech’s QuickMIC is a precision tool for ultrarapid antibiotic susceptibility testing.
Read More
UK Trial to Evaluate POC Test for Early Detection of Sepsis
To detect emergent sepsis, the study aims to develop a rapid diagnostic based on multiple biomarkers.
Read MoreNGS Diagnostic Platform Granted CE Certification
Disqver uses next-generation sequencing of cell-free DNA to detect more than 1,500 bacteria, DNA viruses, fungi, and parasites in a patient’s bloodstream.
Read More
FDA Clears Early Sepsis Indicator from Beckman Coulter
Beckman’s Early Sepsis Indicator is a first-of-its-kind, hematology-based cellular biomarker for identifying patients with sepsis, or those at increased risk of developing sepsis.
Read More
Quality Control Media Help to Reduce Sepsis among Patients Requiring Platelet Transfusion
BD’s quality control media for platelet testing have been CE marked and cleared by FDA.
Read More
World Sepsis Day Raises Awareness of Deadly and Often Misdiagnosed Condition
The World Health Organization has declared sepsis a global health priority; 80% of sepsis deaths in hospitals could be prevented with rapid diagnosis and treatment.
Read More
Genetic Testing Prevents Antibiotic-Related Hearing Loss in Newborns Treated for Sepsis
A bedside test identifies infants with a genetic mutation of the mitochondrial DNA responsible for irreversible hearing loss as an adverse reaction to the antibiotic gentamicin.
Read More
Beckman Coulter Files FDA 510(k) Submission for Early Sepsis Indicator
Offered as part of a routine CBC with differential test, the hematology-based solution alerts emergency department clinicians to the possibility of sepsis earlier than any other indicator.
Read More